Dow Up 1.49% Nasdaq Up 1.67%

Ariad Pharmaceuticals Inc. (ARIA)

-NMS
5.69 Up 0.10(1.85%) 12:54PM EDT - Nasdaq Real Time Price
Prev Close:5.59
Open:5.65
Bid:5.70 x 9600
Ask:5.71 x 6000
1y Target Est:8.72
Beta:1.38
Next Earnings Date: 5-Nov-14ARIA Earnings announcement
Day's Range:5.55 - 5.82
52wk Range:2.15 - 9.83
Volume:2,650,327
Avg Vol (3m):7,454,710
Market Cap:1.06B
P/E (ttm):N/A
EPS (ttm):-1.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARIAUp 1.85%1.06B
NVSUp 1.00%216.13B
PFEUp 1.65%182.40B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):21.34
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.16
Quarterly EPS Est (Sep-14) :-0.30
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback